dr. frederick locke on kte-c19 for refractory nhl
Published 8 years ago • 165 plays • Length 1:57Download video MP4
Download video MP3
Similar videos
-
1:23
dr. locke on the zuma-i trial of kte-c19
-
2:24
locke: kte-c19 for refractory aggressive non-hodgkin lymphoma
-
7:14
frederick locke, md: car t-cell therapy in relapsed/refractory nhl
-
0:23
copy of dr. locke on car t-cell therapy in nhl
-
6:40
frederick locke: axi-cel vs. standard of care in aggressive lbcl
-
2:25
warning signs of lymphoma
-
4:58
doctor explains warning symptoms and signs of hodgkin's lymphoma cancer
-
5:35
the symptoms of lymphoma
-
1:35
asco 2021 - fred locke, md - abstract 2529
-
0:55
frederick l. locke, md, discusses the results of the zuma-1 pivotal phase 2 study with kte-c19
-
1:52
dr. locke on car t-cell therapy in nhl
-
1:36
frederick locke, md, provides his impression of the transcend-nhl study from ash 2019
-
1:06
dr. locke on bridging chemotherapy in patients with non-hodgkin lymphoma
-
0:53
dr. neelapu on next steps with kte-c19 in lymphoma
-
1:50
dr. locke discusses long-term follow-up of zuma-1 trial for nhl
-
1:10
dr. frederick locke at asco 2022: abstract no. 7565
-
1:36
asco 2019: frederick locke, md abstract - tps5596
-
3:49
frederick locke on axi-cel and zuma-7
-
4:11
car t-cell therapies for relapsed/refractory nhl
-
0:58
dr. karmali on fda approval of kte-c19 in non-hodgkin lymphoma
-
4:26
non-hodgkin lymphoma: symptoms & treatment | stanford
-
2:08
dr. ghosh on the benefits of lisocabtagene maraleucel in relapsed/refractory nhl